Stem-cell bill won’t end controversy over safety – Jacksonville Daily Progress
|
Stem–cell bill won’t end controversy over safety
Jacksonville Daily Progress AUSTIN — Wiping away tears, Rep. Drew Springer made a dramatic speech in the last days of the just-ended legislative session, urging lawmakers to approve “investigational” stem–cell treatments in Texas. The Muenster Republican told House members that … Stem Cell Therapies Market Trends, Regulations And Competitive Landscape Outlook to 2025satPRnews (press release) |
|
Stem–cell bill won’t end controversy over safety
Jacksonville Daily Progress AUSTIN — Wiping away tears, Rep. Drew Springer made a dramatic speech in the last days of the just-ended legislative session, urging lawmakers to approve “investigational” stem–cell treatments in Texas. The Muenster Republican told House members that … Stem Cell Therapies Market Trends, Regulations And Competitive Landscape Outlook to 2025satPRnews (press release) |
Wall Street Pit |
Breakthrough Gene Therapy Approach Raises Hopes For Patients With Blood Cancer
Wall Street Pit The process works by removing immune system cells called T cells from a patient’s blood, after which, the filtered blood is modified to contain a cancer-targeting gene, then re-injected into the patient to seek and destroy cancer cells. It’s being … A First: All Respond to Gene Therapy in a Blood Cancer StudyBioscience Technology Cancer Cure Latest News 2017: Promising Results for CAR T-Cell TherapyChristian Post |
|
Cancer Immunotherapy Nanoparticle Plays Offense and Defense …
Genetic Engineering & Biotechnology News Two kinds of cancer immunotherapy may be provided by a dual-targeting nanoparticle, one coated with both checkpoint inhibitory and T-cell-stimulating … |
|
Myonexus Launches Development of Gene Therapies Targeting Limb-Girdle MD
Muscular Dystrophy News Launch plans include the accelerated development of five investigational gene therapies that have the potential to become the first standard-of-care therapies for LGMDs. Myonexus’ pipeline includes three clinical-stage gene therapy programs (LGMD2E, … |
|
VBL Wins $2.5M Grant to Progress Pivotal-Stage Anticancer Gene Therapy
Genetic Engineering & Biotechnology News VBL Therapeutics won an ILS8.75 (approximately $2.5 million) grant from the Israel Innovation Authority to support continued clinical development of the firm’s lead Phase III-stage gene therapy ofranergene obadenovec (VB-111). The anti-angiogenic … |
|
ASC Biosciences, Inc. Signs Letter Of Intent With Stem Cell Development Fund LLC for Staged Funding in Support of …
PR Newswire (press release) PALM DESERT, Calif., June 8, 2017 /PRNewswire/ — ASC Biosciences, Inc. (formerly Nevis Capital Corporation) (“ASC”) (OTC Pink Open Markets: ASCW) is pleased to announce it has enter into a Letter Of Intent (LOI) with Stem Cell Development Fund to … |